113 related articles for article (PubMed ID: 10516943)
1. Trimethoprim/sulfamethoxazole does not affect the steady-state disposition of indinavir.
Sturgill MG; Seibold JR; Boruchoff SE; Yeh KC; Haddix H; Deutsch P
J Clin Pharmacol; 1999 Oct; 39(10):1077-84. PubMed ID: 10516943
[TBL] [Abstract][Full Text] [Related]
2. The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin.
Boruchoff SE; Sturgill MG; Grasing KW; Seibold JR; McCrea J; Winchell GA; Kusma SE; Deutsch PJ
Clin Pharmacol Ther; 2000 Apr; 67(4):351-9. PubMed ID: 10801243
[TBL] [Abstract][Full Text] [Related]
3. No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.
Purkins L; Wood N; Kleinermans D; Love ER
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):62-8. PubMed ID: 14616416
[TBL] [Abstract][Full Text] [Related]
4. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.
Hamzeh FM; Benson C; Gerber J; Currier J; McCrea J; Deutsch P; Ruan P; Wu H; Lee J; Flexner C;
Clin Pharmacol Ther; 2003 Mar; 73(3):159-69. PubMed ID: 12621381
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.
De Wit S; Debier M; De Smet M; McCrea J; Stone J; Carides A; Matthews C; Deutsch P; Clumeck N
Antimicrob Agents Chemother; 1998 Feb; 42(2):223-7. PubMed ID: 9527763
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
Brown MP; Gronwall R; Castro L
Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole (TMP/SMX) potentiates indinavir nephrotoxicity.
de Araujo M; Seguro AC
Antivir Ther; 2002 Sep; 7(3):181-4. PubMed ID: 12487385
[TBL] [Abstract][Full Text] [Related]
9. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin.
Damle BD; Mummaneni V; Kaul S; Knupp C
Antimicrob Agents Chemother; 2002 Feb; 46(2):385-91. PubMed ID: 11796346
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Safety of Sulfamethoxazole-Trimethoprim After Oral Administration of Single and Multiple Doses to Rhode Island Red Chickens (
Petritz OA; Enomoto H; Meyer EG; Thomson A; Baynes RE; Flammer K
J Avian Med Surg; 2023 Jun; 37(1):1-12. PubMed ID: 37358198
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers.
Hsu A; Granneman GR; Cao G; Carothers L; Japour A; El-Shourbagy T; Dennis S; Berg J; Erdman K; Leonard JM; Sun E
Antimicrob Agents Chemother; 1998 Nov; 42(11):2784-91. PubMed ID: 9797204
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of milk thistle and indinavir in healthy subjects.
DiCenzo R; Shelton M; Jordan K; Koval C; Forrest A; Reichman R; Morse G
Pharmacotherapy; 2003 Jul; 23(7):866-70. PubMed ID: 12885100
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.
Levin GM; Nelson LA; DeVane CL; Preston SL; Eisele G; Carson SW
Psychopharmacol Bull; 2001; 35(2):62-71. PubMed ID: 12397887
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic drug-drug interaction study of delavirdine and indinavir in healthy volunteers.
Ferry JJ; Herman BD; Carel BJ; Carlson GF; Batts DH
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):252-9. PubMed ID: 9665503
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
Fox BC; Sollinger HW; Belzer FO; Maki DG
Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings.
Forna F; McConnell M; Kitabire FN; Homsy J; Brooks JT; Mermin J; Weidle PJ
AIDS Rev; 2006; 8(1):24-36. PubMed ID: 16736949
[TBL] [Abstract][Full Text] [Related]
18. Administration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir.
Aarnoutse RE; Wasmuth JC; Fätkenheuer G; Schneider K; Schmitz K; de Boo TM; Reiss P; Hekster YA; Burger DM; Rockstroh JK
Antivir Ther; 2003 Aug; 8(4):309-14. PubMed ID: 14518700
[TBL] [Abstract][Full Text] [Related]
19. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after oral single- and multiple-dose administration to healthy pigs.
Mengelers MJ; van Gogh ER; Huveneers MB; Hougee PE; Kuiper HA; Pijpers A; Verheijden JH; van Miert AS
Vet Res Commun; 2001 Aug; 25(6):461-81. PubMed ID: 11519678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
